Assessment of Pyroptosis-Related Indicators as Potential Biomarkers and Their Association with Severity in Patients with Liver Cirrhosis

References

• Mazumder NR, Celaj S, Atiemo K, et al. Liver-related mortality is similar among men and women with cirrhosis. J Hepatol. 2020. doi:10.1016/j.jhep.2020.04.022
   PubMedGoogle Scholar
• Crismale JF, Friedman SL. Acute Liver Injury and Decompensated Cirrhosis. Med Clin North Am. 2020;104(4):647–662. doi:10.1016/j.mcna.2020.02.010
   PubMed Web of Science ®Google Scholar
• Haj M, Rockey DC. Predictors of clinical outcomes in cirrhosis patients. Curr Opin Gastroenterol. 2018;34(4):266–271. doi:10.1097/MOG.0000000000000450
   PubMed Web of Science ®Google Scholar
• Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer GZ. Non-invasive diagnosis of liver fibrosis and cirrhosis. World j Gastroenterol. 2015;21(41):11567–11583. doi:10.3748/wjg.v21.i41.11567
   PubMed Web of Science ®Google Scholar
• Iredale JP, Thompson A, Henderson NC. Extracellular matrix degradation in liver fibrosis: biochemistry and regulation. Biochim Biophys Acta. 2013;1832(7):876–883. doi:10.1016/j.bbadis.2012.11.002
   PubMed Web of Science ®Google Scholar
• Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199–210. doi:10.1002/path.2277
   PubMed Web of Science ®Google Scholar
• Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest. 2017;127(1):55–64. doi:10.1172/JCI88881
   PubMed Web of Science ®Google Scholar
• Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol. 2013;59(3):583–594. doi:10.1016/j.jhep.2013.03.033
   PubMed Web of Science ®Google Scholar
• Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7(2):99–109. doi:10.1038/nrmicro2070
   PubMed Web of Science ®Google Scholar
• Yuk JM, Silwal P, Jo EK. Inflammasome and Mitophagy Connection in Health and Disease. Int J Mol Sci. 2020;21(13). doi:10.3390/ijms21134714
   PubMed Web of Science ®Google Scholar
• Gong W, Shi Y, Ren J. Research progresses of molecular mechanism of pyroptosis and its related diseases. Immunobiology. 2020;225(2):151884. doi:10.1016/j.imbio.2019.11.019
   PubMed Web of Science ®Google Scholar
• Al Mamun A, Wu Y, Jia C, et al. Role of pyroptosis in liver diseases. Int Immunopharmacol. 2020;84:106489. doi:10.1016/j.intimp.2020.106489
   PubMed Web of Science ®Google Scholar
• Wree A, Eguchi A, McGeough MD, et al. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology. 2014;59(3):898–910. doi:10.1002/hep.26592
   PubMed Web of Science ®Google Scholar
• Yaping Z, Ying W, Luqin D, Ning T, Xuemei A, Xixian Y. Mechanism of interleukin-1beta-induced proliferation in rat hepatic stellate cells from different levels of signal transduction. APMIS. 2014;122(5):392–398. doi:10.1111/apm.12155
   PubMed Web of Science ®Google Scholar
• Khan F, Peltekian KM, Peterson TC. Effect of interferon-alpha, ribavirin, pentoxifylline, and interleukin-18 antibody on hepatitis C sera-stimulated hepatic stellate cell proliferation. J Interferon Cytokine Res. 2008;28(11):643–651. doi:10.1089/jir.2007.0123
   PubMed Web of Science ®Google Scholar
• Mridha AR, Wree A, Robertson AAB, et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol. 2017;66(5):1037–1046. doi:10.1016/j.jhep.2017.01.022
   PubMed Web of Science ®Google Scholar
• Dixon LJ, Berk M, Thapaliya S, Papouchado BG, Feldstein AE. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis. Lab Invest. 2012;92(5):713–723. doi:10.1038/labinvest.2012.45
   PubMed Web of Science ®Google Scholar
• Durand F, Valla D. Assessment of the prognosis of cirrhosis: child-Pugh versus MELD. J Hepatol. 2005;42 Suppl(1):S100–7. doi:10.1016/j.jhep.2004.11.015
   PubMedGoogle Scholar
• Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-Cardenas E, Sanchez-Avila F, Vargas-Vorackova F. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol. 2008;7(4):350–357.
   PubMed Web of Science ®Google Scholar
• Snyder SR, KivIehan SM, Collopy KT. Cirrhosis and Its Complications. Catch this liver scarring problem early, because its effects can be life-threatening. EMS World. 2015;44(10):32–37.
   PubMedGoogle Scholar
• Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838–851. doi:10.1016/S0140-6736(08)60383-9
   PubMed Web of Science ®Google Scholar
• Xia X, Wang X, Zheng Y, Jiang J, Hu J. What role does pyroptosis play in microbial infection? J Cell Physiol. 2019;234(6):7885–7892. doi:10.1002/jcp.27909
   PubMed Web of Science ®Google Scholar
• Xia X, Wang X, Cheng Z, et al. The role of pyroptosis in cancer: pro-cancer or pro-”host”? Cell Death Dis. 2019;10(9):650. doi:10.1038/s41419-019-1883-8
   PubMed Web of Science ®Google Scholar
• Pinar AA, Scott TE, Huuskes BM, Tapia Caceres FE, Kemp-Harper BK, Samuel CS. Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis. Pharmacol Ther. 2020;209:107511. doi:10.1016/j.pharmthera.2020.107511
   PubMed Web of Science ®Google Scholar
• Sayan M, Mossman BT. The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases. Part Fibre Toxicol. 2016;13(1):51. doi:10.1186/s12989-016-0162-4
   PubMed Web of Science ®Google Scholar
• Lorenz G, Darisipudi MN, Anders HJ. Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis. Nephrology Dialysis Transplantation. 2014;29(1):41–48. doi:10.1093/ndt/gft332
   PubMed Web of Science ®Google Scholar
• Negash AA, Olson RM, Griffin S, Gale M. Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activation. PLoS Pathog. 2019;15(2):e1007593. doi:10.1371/journal.ppat.1007593
   PubMed Web of Science ®Google Scholar
• Xie WH, Ding J, Xie XX, et al. Hepatitis B virus X protein promotes liver cell pyroptosis under oxidative stress through NLRP3 inflammasome activation. Inflammation Res. 2020;69(7):683–696. doi:10.1007/s00011-020-01351-z
   PubMed Web of Science ®Google Scholar
• Khanova E, Wu R, Wang W, et al. Pyroptosis by caspase 11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology. 2018;67(5):1737–1753. doi:10.1002/hep.29645
   PubMed Web of Science ®Google Scholar
• Yang Q, Shi Y, Yang Y, Lou G, Chen Z. The sterile inflammation in the exacerbation of HBV-associated liver injury. Mediators Inflamm. 2015;2015:508681. doi:10.1155/2015/508681
   PubMed Web of Science ®Google Scholar
• Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis. World j Gastroenterol. 2009;15(44):5505–5510. doi:10.3748/wjg.15.5505
   PubMed Web of Science ®Google Scholar
• Ribeiro TC, Chebli JM, Kondo M, Gaburri PD, Chebli LA, Feldner AC. Spontaneous bacterial peritonitis: how to deal with this life-threatening cirrhosis complication? Ther Clin Risk Manag. 2008;4(5):919–925. doi:10.2147/tcrm.s2688
   PubMedGoogle Scholar
• Riggio O, Angeloni S. Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis. World j Gastroenterol. 2009;15(31):3845–3850. doi:10.3748/wjg.15.3845
   PubMed Web of Science ®Google Scholar
• Li YT, Huang JR, Peng ML. Current Status and Prospects of Spontaneous Peritonitis in Patients with Cirrhosis. Biomed Res Int. 2020;2020:3743962. doi:10.1155/2020/3743962
   PubMed Web of Science ®Google Scholar
• Bellot P, Frances R, Such J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int. 2013;33(1):31–39. doi:10.1111/liv.12021
   PubMed Web of Science ®Google Scholar
• Zhou CB, Fang JY. The role of pyroptosis in gastrointestinal cancer and immune responses to intestinal microbial infection. Biochimica Et Biophysica Acta Rev Cancer. 2019;1872(1):1–10. doi:10.1016/j.bbcan.2019.05.001
   PubMed Web of Science ®Google Scholar